Destination Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$693K	Buy	1,552 +14	+0.9%	+$6.53K	0.02%	178
2025 Q4	$697K	Sell	1,538 -104	-6%	-$44.8K	0.02%	167
2025 Q3	$643K	Buy	1,642 +89	+6%	+$37.2K	0.02%	158
2025 Q2	$691K	Sell	1,553 -1,724	-53%	-$794K	0.02%	148
2025 Q1	$1.59M	Sell	3,277 -252	-7%	-$117K	0.05%	116
2024 Q4	$1.42M	Buy	3,529 +168	+5%	+$77.9K	0.04%	118
2024 Q3	$1.56M	Buy	3,361 +144	+4%	+$69.2K	0.05%	117
2024 Q2	$1.51M	Buy	3,217 +17	+0.5%	+$7.38K	0.05%	113
2024 Q1	$1.34M	Buy	3,200 +3	+0.1%	+$1.27K	0.04%	120
2023 Q4	$1.3M	Buy	3,197 +107	+3%	+$39.5K	0.05%	117
2023 Q3	$1.07M	Sell	3,090 -2	-0.1%	-$699	0.04%	114
2023 Q2	$1.09M	Hold	3,092	–	–	0.04%	115
2023 Q1	$974K	Sell	3,092 -100	-3%	-$30K	0.04%	118
2022 Q4	$922K	Buy	3,192 +100	+3%	+$30.5K	0.04%	120
2022 Q3	$895K	Hold	3,092	–	–	0.04%	117
2022 Q2	$871K	Sell	3,092 -6	-0.2%	-$1.61K	0.04%	121
2022 Q1	$808K	Buy	3,098 +11	+0.4%	+$2.61K	0.03%	120
2021 Q4	$678K	Hold	3,087	–	–	0.02%	128
2021 Q3	$560K	Sell	3,087 -44	-1%	-$8.59K	0.02%	123
2021 Q2	$631K	Buy	3,131 +3	+0.1%	+$628	0.02%	123
2021 Q1	$672K	Buy	3,128 +7	+0.2%	+$1.54K	0.03%	118
2020 Q4	$738K	Buy	3,121 +23	+0.7%	+$5.28K	0.03%	110
2020 Q3	$843K	Hold	3,098	–	–	0.04%	99
2020 Q2	$899K	Sell	3,098 -347	-10%	-$94.1K	0.05%	95
2020 Q1	$820K	Buy	+3,445	New	+$790K	0.05%	104
2019 Q2	–	Sell	-17	Closed	-$3K	–	758
2019 Q1	$3K	Buy	+17	New	+$3.14K	﹤0.01%	578